Mrs Margaret Fitch Mcclellan, AGPCNP, MSN, RN | |
5353 Reynolds St Ste 107, Savannah, GA 31405-6089 | |
(912) 819-5750 | |
(912) 819-5752 |
Full Name | Mrs Margaret Fitch Mcclellan |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 9 Years |
Location | 5353 Reynolds St Ste 107, Savannah, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013365550 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LG0600X | Nurse Practitioner - Gerontology | RN222787 (Georgia) | Secondary |
363LA2200X | Nurse Practitioner - Adult Health | RN222787 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Candler Hospital | Savannah, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sjc Oncology Services - Georgia, Llc | 8426086901 | 14 |
News Archive
Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit burn and accident victims.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis PSA, its construct to fight prostate cancer.
› Verified 3 days ago
Entity Name | Sjc Oncology Services - Georgia, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710196589 PECOS PAC ID: 8426086901 Enrollment ID: O20050727000606 |
News Archive
Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit burn and accident victims.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis PSA, its construct to fight prostate cancer.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Margaret Fitch Mcclellan, AGPCNP, MSN, RN Po Box 15238, Savannah, GA 31416-1938 Ph: (912) 354-4813 | Mrs Margaret Fitch Mcclellan, AGPCNP, MSN, RN 5353 Reynolds St Ste 107, Savannah, GA 31405-6089 Ph: (912) 819-5750 |
News Archive
Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit burn and accident victims.
Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.
Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that the Food and Drug Administration has completed its review and cleared the Investigational New Drug application for SGX942 for the treatment of oral mucositis resulting from radiation and/or chemotherapy treatment in head and neck cancer patients.
Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on August 10, 2011 to discuss the CMC, pharmacology, toxicology, and clinical plans for Advaxis PSA, its construct to fight prostate cancer.
› Verified 3 days ago
Glenda Laine Eloge, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5353 Reynolds St, Ste 300, Savannah, GA 31405 Phone: 912-355-6005 Fax: 912-355-5643 | |
Ms. Deborah Evelyn Kemp, APRN, BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1302 Drayton St, Savannah, GA 31401 Phone: 912-443-9409 Fax: 912-443-1843 | |
Deanna M Wildes, RN, BSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4750 Waters Avenue, Suite 500, Savannah, GA 31404 Phone: 912-352-8346 Fax: 912-355-1414 | |
Abegail Delez Xiang, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6301 Abercorn St, Savannah, GA 31405 Phone: 912-352-8700 Fax: 912-650-6805 | |
Jackie M Kehrli, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4750 Waters Ave Ste 202, Savannah, GA 31404 Phone: 912-350-7412 Fax: 912-350-7297 | |
Caroline Shealy Sauers, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6602 Waters Ave Bldg C, Savannah, GA 31406 Phone: 912-354-7676 Fax: 912-354-6040 | |
Stacy Eagle, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6602 Waters Ave, Savannah, GA 31406 Phone: 912-354-7676 |